YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Sanofi, Massachusetts General Hospital, Sign Trans Med Agreement

October 9, 2012 | Sanofi has announced a two-year agreement with Massachusetts General Hospital (MGH) aimed at furthering translational medicine research to develop new treatments for various types of hematological malignancies and solid tumors. The project-based collaboration unites scientists from MGH and Sanofi, with the goal of maximizing the strengths of both academic and industry cross-organizational expertise, and will include both pre-clinical and clinical translational research to elucidate questions from proof-of-concept to tolerability, efficacy and effectiveness. Press Release



Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Terry Manning, 781.972.1349.